The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,460,455 in first-year total cost, median $1,230,228.
Most frequent study sections
- Special Emphasis Panel[ZEY1 VSN (03)]2
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- MICHIGAN STATE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Translational Gene Therapy for CNGB1 Retinitis Pigmentosa1R24EY027285-01A1 | HAUSWIRTH, WILLIAM WMICHALAKIS, STYLIANOSPETERSEN-JONES, SIMONTSANG, STEPHEN H | MICHIGAN STATE UNIVERSITY, MI | $1,253,534 | ZEY1 |
| 2018 | Multipotent ABCB5-positive cell therapeutics for corneal disease1R24EY028767-01 | FRANK, MARKUS H.FRANK, NATASHA YKSANDER, BRUCE R | BRIGHAM AND WOMEN'S HOSPITAL, MA | $1,206,921 | ZEY1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.